Evidence map›Paper›PMID 35812397›Full record

ArticleFrontiers in immunology2022

Pathogenic Leptospires Limit Dendritic Cell Activation Through Avoidance of TLR4 and TRIF Signaling.

Julie Cagliero, Frédérique Vernel-Pauillac, Gerald Murray, Ben Adler, Mariko Matsui, Catherine Werts

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.4field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Veterinary sciences · 2025
    Article
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 3 countries.

Julie CaglieroInstitut Pasteur de Nouvelle-Calédonie, member of the Pasteur Network, Immunity and Inflammation Group (GIMIN), Noumea, New Caledonia.
Frédérique Vernel-PauillacInstitut Pasteur, Université de Paris, CNRS UMR6047, INSERM U1306, Unité de Biologie et Génétique de la Paroi bactérienne, F-75015 Paris, France.
Gerald MurrayDepartment of Microbiology, Biomedicine Discovery Institute, Monash University, Melbourne, Australia.
Ben AdlerDepartment of Microbiology, Biomedicine Discovery Institute, Monash University, Melbourne, Australia.
Mariko MatsuiInstitut Pasteur de Nouvelle-Calédonie, member of the Pasteur Network, Immunity and Inflammation Group (GIMIN), Noumea, New Caledonia.
Catherine WertsInstitut Pasteur, Université de Paris, CNRS UMR6047, INSERM U1306, Unité de Biologie et Génétique de la Paroi bactérienne, F-75015 Paris, France.
Institut Pasteur de Nouvelle Calédonie · NCAustralian Regenerative Medicine Institute · AUInserm · FRInstitut Pasteur · FRMonash University · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

LeptospirosisToll-Like Receptor 4Adaptor Proteins, Vesicular TransportAnimalsDendritic CellsHumansLipopolysaccharidesMammalsMiceMice, TransgenicAdaptor Proteins, Vesicular TransportLipopolysaccharidesTICAM1 protein, humanTicam1 protein, mouseTLR4 protein, humanTlr4 protein, mouseToll-Like Receptor 4CD40DC-SIGNdendritic cellsimmune evasionLeptospiraMHC-IItoll-like receptor 4TRIF

Identifiers

PMID35812397
PMCPMC9258186
OpenAlexW4283321112

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.